contact[at]op2lysis.com

Search for:

Orphan drug designation granted to OptPA for the treatment of non-traumatic spontaneous intracerebral hemorrhage by the European Commission

Home
Corporate
Orphan drug designation granted to OptPA for the treatment of non-traumatic spontaneous intracerebral hemorrhage by the European Commission

ODD-EMA Télécharger

[hfe_template id="12778"]

2026 Lysara Biosciences. All rights reserved. Website by AlexLordDesign